Furthermore, pretreatment with the rosiglitazone (an insulin sensitizer) attenuates striatal DA neurodegeneration in 6‐OHDA‐lesioned model of PD by increase in GFAP expression and astrocyte function in the SNpc and striatum.56 This evidence concerns the gene GFAP and Parkinson disease.